Cargando...

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection

Immunomodulatory and analgesic effects of dexamethasone are clinically well established, and this synthetic corticosteroid acts as an agonist of glucocorticoid receptors. Early results of the RECOVERY Trial from the United Kingdom and others suggest certain benefits of dexamethasone against COVID-19...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Per Med
Main Authors: Vohra, Manik, Sharma, Anu Radha, Satyamoorthy, Kapaettu, Rai, Padmalatha S
Formato: Artigo
Idioma:Inglês
Publicado: Future Medicine Ltd 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8186476/
https://ncbi.nlm.nih.gov/pubmed/34086487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme-2020-0183
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!